China SXT Pharmaceuticals (SXTC) Current Deferred Tax Assets (2018 - 2021)

China SXT Pharmaceuticals' Current Deferred Tax Assets history runs 3 years deep, the most recent figure standing at $504522.0 for Q3 2021.

• In Q3 2021, Current Deferred Tax Assets fell 4.87% year-over-year to $504522.0; the TTM figure through Sep 2021 stood at $504522.0 (down 4.87% YoY), while the FY2021 annual figure was $547807.0, up 7.28% from the prior year.
• Current Deferred Tax Assets was $504522.0 for Q3 2021 at China SXT Pharmaceuticals, down from $547807.0 in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $547807.0 in Q1 2021 to a low of -$48454.0 in Q3 2018.
• Historically, Current Deferred Tax Assets has averaged $408972.8 across 3 years, with a median of $510617.0 in 2020.
• Biggest YoY gain for Current Deferred Tax Assets was 7.28% in 2021; the steepest drop was 4.87% in 2021.
• A 3-year view of Current Deferred Tax Assets shows it stood at -$48454.0 in 2018, then soared by 1194.59% to $530372.0 in 2020, then decreased by 4.87% to $504522.0 in 2021.
• The last three Current Deferred Tax Assets figures came in at $504522.0 (Q3 2021), $547807.0 (Q1 2021), and $530372.0 (Q3 2020), per Business Quant data.